Open, Randomized, Phase I Study in Subjects With Type 2 Diabetes Mellitus Treated With Metformin to Evaluate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa.
Phase of Trial: Phase I
Latest Information Update: 09 Jul 2010
At a glance
- Drugs AZD 1656; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 09 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2010 New trial record